Correlation Between Denali Therapeutics and OS Therapies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and OS Therapies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and OS Therapies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and OS Therapies Incorporated, you can compare the effects of market volatilities on Denali Therapeutics and OS Therapies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of OS Therapies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and OS Therapies.

Diversification Opportunities for Denali Therapeutics and OS Therapies

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Denali and OSTX is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and OS Therapies Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OS Therapies and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with OS Therapies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OS Therapies has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and OS Therapies go up and down completely randomly.

Pair Corralation between Denali Therapeutics and OS Therapies

Given the investment horizon of 90 days Denali Therapeutics is expected to under-perform the OS Therapies. But the stock apears to be less risky and, when comparing its historical volatility, Denali Therapeutics is 3.12 times less risky than OS Therapies. The stock trades about 0.0 of its potential returns per unit of risk. The OS Therapies Incorporated is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  251.00  in OS Therapies Incorporated on October 4, 2024 and sell it today you would earn a total of  177.00  from holding OS Therapies Incorporated or generate 70.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy21.62%
ValuesDaily Returns

Denali Therapeutics  vs.  OS Therapies Incorporated

 Performance 
       Timeline  
Denali Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Denali Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
OS Therapies 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in OS Therapies Incorporated are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, OS Therapies showed solid returns over the last few months and may actually be approaching a breakup point.

Denali Therapeutics and OS Therapies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Denali Therapeutics and OS Therapies

The main advantage of trading using opposite Denali Therapeutics and OS Therapies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, OS Therapies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OS Therapies will offset losses from the drop in OS Therapies' long position.
The idea behind Denali Therapeutics and OS Therapies Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance